The mechanism of diabetes-dependent C3 incorporation into fibrin clots with concomitant effects on clot characteristics adds to our knowledge of the broad aspects of complement functioning in type 1 and, potentially also, type 2 diabetes, and may in due course be extended to related disorders, including obesity and NAFLD. The gene discussed is C3; the disease is obesity disorder.